Neurology 1002 - Neurology Alert - Feb 01, 2006

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Fred Plum, MD
University Professor;
Department of Neurology;
Cornell University Medical College

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman;
Department of Neurology;
Cornell University Medical College
New York, NY

Authors
Dana Leifer, MD
Associate Professor
Neurology
Weill Medical College
Cornell University

Dara G. Jamieson, MD
Associate Professor
Clinical Neurology
Weill Medical College
Cornell University

Cynthia L. Harden, MD
Associate Professor
Neurology and Neuroscience
Weill Cornell Medical
Center of Cornell University

Assistant Editors
Matthew Fink, MD
Vice Chairman
Professor of Clinical Neurology
Weill Medical College
Chief of Division
Stroke and Critical Care Neurology
New York Presbyterian Hospital

Claire Henchcliffe, MD, DPhil
Assistant Professor
Department of Neurology
Weill Medical College
Cornell University

Micheal Rubin, MD
Professor of Clinical Neurology
New York Presbyterian Hospital
Cornell Campus

Alan Z. Segal, MD
Assistant Professor
Department of Neurology
Weill-Cornell Medical College
Attending Neurologist
New York Presbyterian Hospital

Subjects:

  • Cerebral Aneurysms: To Screen or Not to Screen?
  • Genotype-Phenotype Associations in LRRK2 Parkinson's Disease
  • Brain Oxygen Monitoring in Traumatic Brain Injury
  • Headaches at High Altitudes: How Does the Brain React to Increased Elevations Both Acutely and Chronically?
  • ADNFLE
  • Prognosis in CIDP
  • The NORVIT Trial

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present "basic science? lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Fred Plum, MD reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. The Peer Reviewer, M. Flint Beal, MD, author Dana Leifer, MD, and assistant editor Matthew Fink, MD all report no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company having ties or related to this field of study. Assistant editor Claire Henchcliffe, MD, DPhil is on the speaker's bureau for GlaxoSmithKline, Teva/Eisai, and Boehringer Ingelheim. Author Dara G. Jamieson, MD is a consultant for Boehringer Ingelheim and Merck, and is on the speaker's bureau for Boehringer Ingelheim, Merck, Ortho-McNeil, and Pfizer. Author Cynthia L. Harden, MD does research for Schwarz, GlaxoSmithKline, UCB, Ortho, and Ivax, is a consultant for Cyberonics and GlaxoSmithKline, and is on the speaker's bureau for Cyberonics, GlaxoSmithKline, UCB, Novartis, Pfizer, and Ortho. Assistant editor Michael Rubin, MD is on the speaker's bureau for Athena Diagnostics, and does research for Pfizer and Merck. Assistant editor Alan Z. Segal, MD is on the speaker's bureau of Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.